{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:12:44Z","timestamp":1780672364724,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacepopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACEP Open"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.acepjo.2025.100045","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:25:13Z","timestamp":1738203913000},"page":"100045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Case of Intussusception With Bowel Obstruction in a Gastric Roux-en-Y Patient Prescribed Semaglutide"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0148-5881","authenticated-orcid":false,"given":"Suresh K.","family":"Pavuluri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Toumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acepjo.2025.100045_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.acepjo.2025.100045_bib2","series-title":"StatPearls","article-title":"Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs)","author":"Latif","year":"2024"},{"issue":"8","key":"10.1016\/j.acepjo.2025.100045_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3949\/ccjm.89a.21110","article-title":"The role of GLP-1 receptor agonists in managing type 2 diabetes","volume":"89","author":"Nachawi","year":"2022","journal-title":"Cleve Clin J Med"},{"issue":"24","key":"10.1016\/j.acepjo.2025.100045_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.acepjo.2025.100045_bib5","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.acepjo.2025.100045_bib6","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acepjo.2025.100045_bib7","author":"Montero"},{"key":"10.1016\/j.acepjo.2025.100045_bib8","author":"Morgan"},{"issue":"5","key":"10.1016\/j.acepjo.2025.100045_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.soard.2021.01.006","article-title":"Incidence and treatment of intussusception following Roux-en-Y gastric bypass: a systematic review and meta-analysis","volume":"17","author":"Oor","year":"2021","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1016\/j.acepjo.2025.100045_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10151-019-01980-5","article-title":"Adult intussusception: a systematic review and meta-analysis","volume":"23","author":"Hong","year":"2019","journal-title":"Tech Coloproctol"},{"issue":"6","key":"10.1016\/j.acepjo.2025.100045_bib11","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cgh.2023.08.034","article-title":"Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: Scandinavian cohort study","volume":"22","author":"Ueda","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3-4","key":"10.1016\/j.acepjo.2025.100045_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.acepjo.2025.100045_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajem.2024.01.010","article-title":"GLP-1 agonists: a review for emergency clinicians","volume":"78","author":"Long","year":"2024","journal-title":"Am J Emerg Med"},{"issue":"18","key":"10.1016\/j.acepjo.2025.100045_bib14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.acepjo.2025.100045_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.acepjo.2025.100045_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102427","article-title":"Adverse drug reactions of GLP-1 agonists: a systematic review of case reports","volume":"16","author":"Shetty","year":"2022","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.acepjo.2025.100045_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/dia.2014.0188","article-title":"Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"17","author":"Sun","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.acepjo.2025.100045_bib18","article-title":"Glucagon-like peptide analogues for type 2 diabetes mellitus","volume":"2011","author":"Shyangdan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.acepjo.2025.100045_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/5584_2020_496","article-title":"Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity","volume":"1307","author":"Maselli","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"10.1016\/j.acepjo.2025.100045_bib20","article-title":"SAT675 GLP-1RA therapy and intussusception: a case report of bowel telescoping in anobese patient after successful weight loss on therapy","volume":"7","author":"Alqaisi","year":"2023","journal-title":"J\u00a0Endocr Soc"},{"issue":"4","key":"10.1016\/j.acepjo.2025.100045_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4158\/EP11290.OR","article-title":"Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting","volume":"18","author":"Lando","year":"2012","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.acepjo.2025.100045_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.acepjo.2025.100045_bib23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/dom.12926","article-title":"Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): data from randomized controlled trials","volume":"19","author":"Monami","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.acepjo.2025.100045_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111806","article-title":"The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis","volume":"215","author":"Lomeli","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.acepjo.2025.100045_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/oby.23922","article-title":"Semaglutide 2.4 mg\/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery","volume":"32","author":"Bonnet","year":"2024","journal-title":"Obesity (Silver Spring)"}],"container-title":["JACEP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115225000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115225000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T21:29:45Z","timestamp":1745011785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2688115225000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2688115225000037"],"URL":"https:\/\/doi.org\/10.1016\/j.acepjo.2025.100045","relation":{},"ISSN":["2688-1152"],"issn-type":[{"value":"2688-1152","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Case of Intussusception With Bowel Obstruction in a Gastric Roux-en-Y Patient Prescribed Semaglutide","name":"articletitle","label":"Article Title"},{"value":"JACEP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acepjo.2025.100045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Emergency Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100045"}}